Management of malignant hypertension.
D000284:Administration, Oral; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D003000:Clonidine / Q000627:therapeutic use; D003981:Diazoxide / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005665:Furosemide / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006974:Hypertension, Malignant / Q000188:drug therapy*; D007275:Injections, Intravenous; D008914:Minoxidil / Q000627:therapeutic use; D009599:Nitroprusside / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011654:Pulmonary Edema / Q000150:complications; D013997:Time Factors; D014511:Uremia / Q000150:complications
D000959:Antihypertensive Agents; D004232:Diuretics; D009599:Nitroprusside; D006830:Hydralazine; D008914:Minoxidil; D005665:Furosemide; D011433:Propranolol; D003000:Clonidine; D003981:Diazoxide